Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03440008 · ClinicalTrials.gov registry record
Improving the Detection, Classification and Treatment of Misaligned Arthritic Ankles
A clinical trial, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- 33
- Enrollment target
NCT03440008: Clinical Trial study, sponsored by VA Office of Research and Development.
NCT03440008 is a clinical trial that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03440008 was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The Veteran population is prone to foot and ankle maladies from common injuries such as sprains, and diseases such as ankle osteoarthritis (cartilage damage). More specific to Veterans are prior service injuries of the foot and ankle, which historically account for nearly a quarter of injuries received. These injuries include bone fractures and ligament damage. Some of these injuries may lead to poor ankle joint alignment, which over time could lead to osteoarthritis due to abnormal wear on a day to day basis. The goal of this proposal is to use a novel technology - biplane fluoroscopy, to study the movement of ankles which are misaligned in subjects with ankle osteoarthritis. This proposal will also benefit current diagnostic methods with additional information. Last, this proposal will test the effectiveness of a conservative treatment (modified shoe insoles) to correct or reduce the misalignment in ankles. This proposal will create evidence about: the nature of ankle osteoarthritis, the accuracy of diagnosing alignment, and conservative treatment for patients with ankle OA.
Primary Outcome
The 3D movement between the tibia and talus bones will be assessed using biplane fluoroscopy, for OA and control subjects during shod gait.
Interventions
- OTHER Dynamic 3D bone motion capture
- DEVICE wedged insole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2016-12-22 |
| Est. Completion | 2023-11-16 |
Why NCT03440008 stopped before completion
NCT03440008 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Dynamic 3D bone motion capture is the first listed.
NCT03440008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03440008 about?
NCT03440008 is a clinical study titled "Improving the Detection, Classification and Treatment of Misaligned Arthritic Ankles". The Veteran population is prone to foot and ankle maladies from common injuries such as sprains, and diseases such as ankle osteoarthritis (cartilage damage). More specific to Veterans are prior service injuries of the foot and ankle, which historically account for nearly a quarter of injuries recei...
What is the current status of trial NCT03440008?
This trial is currently terminated. The enrollment target is 33 participants. The study started on 2016-12-22. Estimated completion is 2023-11-16.
What interventions are being tested in trial NCT03440008?
The interventions under investigation include: Dynamic 3D bone motion capture (OTHER), wedged insole (DEVICE).
Who is sponsoring clinical trial NCT03440008?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI